Under construction – not a live service
Sign in
Not yet taking people in ThailandNo phase

A health education program to help people on many medicines protect their kidneys

Tests a health education program for people taking many medicines, to help prevent kidney disease.

Plain-language title generated from the registry record
Registry title: Effectiveness of Health Literacy Program for Polypharmacy Patients (HLP-CKD)

Key facts

Where
Nakhon Pathom, ThailandSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 55 and 74 years old?

Source: NCT07622134, who can take part

Where in Thailand

  • Health Promoting HospitalNakhon Pathom, ThailandNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Nakhon Pathom Rajabhat University
Trial code
NCT07622134
Record updated
4 June 2026
Original description
This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.Read full original descriptionShow less

Effectiveness of the Health Literacy Promotion Program to Prevent Chronic Kidney Disease of Patients Who Use Polypharmacy

This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.

Inclusion: Patients aged 55-74 years diagnosed with non-communicable diseases; Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months; Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes); Able to communicate, read, and write in Thai; Willing to participate in the 8-week program and follow-up assessments.

Exclusion: Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5; Having severe cognitive impairment or psychiatric disorders that prevent participation; Having severe complications or being in an unstable clinical condition; Planning to move out of the study area during the 12-week study period.

ClinicalTrials.gov NCT07622134